BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6305607)

  • 1. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
    Vallot T; Mignon M; Mazure R; Bonfils S
    Dig Dis Sci; 1983 Jul; 28(7):577-84. PubMed ID: 6305607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine and cimetidine in Zollinger-Ellison syndrome.
    Mignon M; Vallot T; Mayeur S; Bonfils S
    Br J Clin Pharmacol; 1980 Aug; 10(2):173-4. PubMed ID: 6107118
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma-secretin in management of cimetidine therapy for Zollinger-Ellison syndrome.
    Straus E; Greenstein RJ; Yalow RS
    Lancet; 1978 Jul; 2(8080):73-5. PubMed ID: 78299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine, pH, and Zollinger-Ellison syndrome.
    McCloy RF; Modlin IM
    Lancet; 1977 Nov; 2(8048):1131-2. PubMed ID: 73038
    [No Abstract]   [Full Text] [Related]  

  • 5. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
    Habal FM; Soldin SJ; Greenberg GR
    Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New perspectives in the treatment of Zollinger-Ellison syndrome. Effect of cimetidine].
    Stage JG; Stadil F; Malmstrom J
    Ugeskr Laeger; 1977 Aug; 139(35):2048-52. PubMed ID: 337604
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
    Bonfils S; Mignon M; Vallot ; Mayeur S
    Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine reverses cimetidine-induced mental confusion in a patient with Zollinger-Ellison syndrome.
    Pedrazzoli S; Petrin P; Pasquali C; Militello C; Sperti C; Fregonese V; Simini G
    Arch Surg; 1983 Feb; 118(2):256. PubMed ID: 6295340
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged secretory inhibition during cimetidine treatment in Zollinger-Ellison patients.
    Stage JG; Bonfils S; Mignon M; Stadil F
    Scand J Gastroenterol; 1982 Apr; 17(3):401-4. PubMed ID: 7134867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome.
    Mignon M; Vallot T; Galmiche JP; Dupas JL; Bonfils S
    Digestion; 1980; 20(1):56-61. PubMed ID: 7353734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of gastric acid hypersecretion in the Zollinger-Ellison syndrome with a thioamide derivative (40749 RP). Comparison with ranitidine].
    Bonfils S; Vallot T; Garcia del Risco F; Mignon M
    Gastroenterol Clin Biol; 1986; 10(6-7):486-91. PubMed ID: 3758592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
    Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
    Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
    Bardram L; Stadil F
    Scand J Gastroenterol Suppl; 1989; 166():95-100; discussion 111-3. PubMed ID: 2574912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Vinayek R; Hahne WF; Euler AR; Norton JA; Jensen RT
    Dig Dis Sci; 1993 Oct; 38(10):1857-65. PubMed ID: 8104773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of Zollinger-Ellison syndrome with ranitidine.
    Vezzadini P; Bonora G; Tomassetti P; Pazzaglia M; Labò G
    Int J Tissue React; 1983; 5(4):339-43. PubMed ID: 6323334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of cimetidine resistance in the Zollinger-Ellison syndrome.
    Andersen BN; Larsen NE; Rune SJ; Worning H
    Gut; 1985 Nov; 26(11):1263-5. PubMed ID: 4065699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists. A prospective study.
    Richardson CT; Peters MN; Feldman M; McClelland RN; Walsh JH; Cooper KA; Willeford G; Dickerman RM; Fordtran JS
    Gastroenterology; 1985 Aug; 89(2):357-67. PubMed ID: 2861140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine in clinical use. A review.
    Festen HP; Lamers CB; van Tongeren JH
    Neth J Med; 1980; 23(5):210-7. PubMed ID: 6999368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.